Safety and efficacy of gemcitabine plus nab-paclitaxel therapy in elderly patients with advanced pancreatic cancer

Yu Aoki; Yasutaka Sukawa; Kenta Kawasaki; Takeshi Suzuki; Kenro Hirata; Akiyoshi Kasuga; Eisuke Iwasaki; Yasuo Hamamoto; Hiromasa Takaishi; Takanori Kanai

doi:10.1093/annonc/mdx621.049

Safety and efficacy of gemcitabine plus nab-paclitaxel therapy in elderly patients with advanced pancreatic cancer

Yu Aoki, Yasutaka Sukawa, Kenta Kawasaki, Takeshi Suzuki, Kenro Hirata, Akiyoshi Kasuga, Eisuke Iwasaki, Yasuo Hamamoto, Hiromasa Takaishi, Takanori Kanai

研究成果: Article › 査読

本文言語	English
ページ（範囲）	ix106
ジャーナル	Annals of Oncology
巻	28
DOI	https://doi.org/10.1093/annonc/mdx621.049
出版ステータス	Published - 2017 10月

ASJC Scopus subject areas

血液学
腫瘍学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1093/annonc/mdx621.049

他のファイルとリンク

引用スタイル

@article{2a928a9866ff460d81a7743eee2e0315,

title = "Safety and efficacy of gemcitabine plus nab-paclitaxel therapy in elderly patients with advanced pancreatic cancer",

author = "Yu Aoki and Yasutaka Sukawa and Kenta Kawasaki and Takeshi Suzuki and Kenro Hirata and Akiyoshi Kasuga and Eisuke Iwasaki and Yasuo Hamamoto and Hiromasa Takaishi and Takanori Kanai",

year = "2017",

month = oct,

doi = "10.1093/annonc/mdx621.049",

language = "English",

volume = "28",

pages = "ix106",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Safety and efficacy of gemcitabine plus nab-paclitaxel therapy in elderly patients with advanced pancreatic cancer

AU - Aoki, Yu

AU - Sukawa, Yasutaka

AU - Kawasaki, Kenta

AU - Suzuki, Takeshi

AU - Hirata, Kenro

AU - Kasuga, Akiyoshi

AU - Iwasaki, Eisuke

AU - Hamamoto, Yasuo

AU - Takaishi, Hiromasa

AU - Kanai, Takanori

PY - 2017/10

Y1 - 2017/10

UR - http://www.scopus.com/inward/record.url?scp=85079904508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079904508&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx621.049

DO - 10.1093/annonc/mdx621.049

M3 - Article

C2 - 32120508

SN - 0923-7534

VL - 28

SP - ix106

JO - Annals of Oncology

JF - Annals of Oncology

ER -